InsidersTradesSigma
申报总数
公司
▲ 买入（10 笔）
▼ 卖出（88 笔）
内部人交易记录
首席执行官已披露买入
10
已披露卖出
88
T+90 胜率
60%
T+90 平均收益
+20.9%
基于 5 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Troendle August J., Chief Executive Officer and Chairman of the Board. Director active across 2 companies, notably Medpace Holdings, Inc.. In total, 101 disclosures have been published. Split: 10 buys · 88 sells. Total volume traded: €620.5m. History available since 15 June 2021. The latest transaction was filed on 27 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Troendle August J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报101 总计
650 股@ US$620.27Common StockSEC:0001622058-26-000010:0
673 股@ US$620.380.0024% mcap0.1% 占其流量Common StockSEC:0001622058-26-000008:0
4,000 股@ US$620.030.014% mcap0.3% 占其流量Common StockSEC:0001622058-26-000008:1
13,995 股@ US$624.450.050% mcap1.2% 占其流量Common StockSEC:0000892251-26-000152:0
1,983 股@ US$620.230.0071% mcap0.2% 占其流量Common StockSEC:0000892251-26-000152:1
27,174 股@ US$618.790.10% mcap2.3% 占其流量Common StockSEC:0000892251-26-000125:1
15,609 股@ US$606.470.058% mcap1.3% 占其流量Common StockSEC:0000892251-26-000125:0
11,366 股@ US$601.530.042% mcap1.0% 占其流量Common StockSEC:0000892251-26-000114:0
458 股@ US$600.390.0017% mcap0.0% 占其流量Common StockSEC:0000892251-26-000114:1
5,534 股@ US$601.530.020% mcap0.5% 占其流量Common StockSEC:0001622058-26-000006:0
17,610 股@ US$605.110.063% mcap1.6% 占其流量Common StockSEC:0001622058-26-000006:1
3,728 股@ US$600.850.014% mcap0.3% 占其流量Common StockSEC:0001622058-26-000004:0
3,510 股@ US$600.010.013% mcap0.3% 占其流量Common StockSEC:0001622058-26-000004:1
668 股@ US$590.690.1% 占其流量Common StockSEC:0001622058-25-000023:0
23,178 股@ US$593.252.1% 占其流量Common StockSEC:0001622058-25-000021:0
41,331 股@ US$606.883.9% 占其流量Common StockSEC:0001622058-25-000019:0
59,025 股@ US$607.785.8% 占其流量Common StockSEC:0001622058-25-000017:0
6,830 股@ US$598.490.7% 占其流量Common StockSEC:0001622058-25-000015:0
7,191 股@ US$590.840.7% 占其流量Common StockSEC:0001622058-25-000013:0
14,747 股@ US$595.261.5% 占其流量Common StockSEC:0001622058-25-000011:0
5,312 股@ US$603.230.6% 占其流量Common StockSEC:0001622058-25-000009:0
36,196 股@ US$475.903.0% 占其流量Common StockSEC:0001622058-25-000006:0
620 股@ US$475.000.1% 占其流量Common StockSEC:0001622058-25-000004:0
48,487 股@ US$451.694.0% 占其流量Common StockSEC:0001668397-25-000097:0
37,417 股@ US$54.740.4% 占其流量Common StockSEC:0001668397-25-000033:0
101 条申报中的 25 条
About Troendle August J.
Troendle August J. is Chief Executive Officer and Chairman of the Board, with declared roles at Medpace Holdings, Inc. as CEO and at Coherus BioSciences, Inc. as Director. He has 88 filings in total, and across the sampled filings from 2016-02-11 to 2025-12-04, buys amount to EUR 80782132 and sells to EUR 483686303, with Cession as the modal transaction nature.
